3-{[3-chloro-5-(trifluoromethyl)pyridin-2-yl]sulfanyl}-1-phenyl-5H,6H,7H-cyclopenta[c]pyridine-4-carbonitrile

Catalog No. :
ACRKZR705
CAS No. :
861209-33-8
Molecular Formula :
C21H13ClF3N3S
Molecular Weight :
431.87

IUPAC Name:3-((3-chloro-5-(trifluoromethyl)pyridin-2-yl)thio)-1-phenyl-6,7-dihydro-5H-cyclopenta[c]pyridine-4-carbonitrile

3-{[3-chloro-5-(trifluoromethyl)pyridin-2-yl]sulfanyl}-1-phenyl-5H,6H,7H-cyclopenta[c]pyridine-4-carbonitrile structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g90%$324.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name3-{[3-chloro-5-(trifluoromethyl)pyridin-2-yl]sulfanyl}-1-phenyl-5H,6H,7H-cyclopenta[c]pyridine-4-carbonitrile
IUPAC Name3-((3-chloro-5-(trifluoromethyl)pyridin-2-yl)thio)-1-phenyl-6,7-dihydro-5H-cyclopenta[c]pyridine-4-carbonitrile
MDL No.MFCD03305569
Molecular FormulaC21H13ClF3N3S
Molecular Weight431.87
SMILESN#CC1=C(SC2=NC=C(C(F)(F)F)C=C2Cl)N=C(C3=CC=CC=C3)C4=C1CCC4
InChI KeyXEZSEJXFXCJRHC-UHFFFAOYSA-N
CAS No.861209-33-8

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACRKZR705 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACRKZR705 route product structure diagram
    ACRKZR705861209-33-8
Inquiry

2. ACRKZR705 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACRKZR705 route product structure diagram
    ACRKZR705861209-33-8
Inquiry

Comments (0)